Chemoinformaics analysis of 1-Methylethyl glucosinolate
| Molecular Weight | 361.394 | nRot | 5 |
| Heavy Atom Molecular Weight | 342.242 | nRig | 27 |
| Exact Molecular Weight | 361.05 | nRing | 1 |
| Solubility: LogS | -4.09 | nHRing | 1 |
| Solubility: LogP | 5.92 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 43.4871 |
| nHD | 5 | BPOL | 31.6489 |
| QED | 0.405 |
| Synth | 4.779 |
| Natural Product Likeliness | 3.192 |
| NR-PPAR-gamma | 0.969 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.024 |
| Pgp-sub | 0 |
| HIA | 0.016 |
| CACO-2 | -5.369 |
| MDCK | 0.0000124 |
| BBB | 0.128 |
| PPB | 0.963054 |
| VDSS | 1.013 |
| FU | 0.0241603 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.467 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.96 |
| CYP2c9-inh | 0.104 |
| CYP2c9-sub | 0.417 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.357 |
| CYP3a4-inh | 0.126 |
| CYP3a4-sub | 0.359 |
| CL | 2.348 |
| T12 | 0.026 |
| hERG | 0.002 |
| Ames | 0.047 |
| ROA | 0.044 |
| SkinSen | 0.03 |
| Carcinogencity | 0.019 |
| EI | 0.67 |
| Respiratory | 0.937 |
| NR-Aromatase | 0.576 |
| Antiviral | Yes |
| Prediction | 0.788075 |